CBS 2019
CBSMD教育中心
中 文

Fractional Flow Reserve

Abstract

Recommended Article

Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study Physiology-Based Revascularization: A New Approach to Plan and Optimize Percutaneous Coronary Intervention: State-of-the-Art Review Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI) Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery Influence of Local Myocardial Damage on Index of Microcirculatory Resistance and Fractional Flow Reserve in Target and Nontarget Vascular Territories in a Porcine Microvascular Injury Model FFR-guided multivessel stenting reduces urgent revascularization compared with infarct-related artery only stenting in ST-elevation myocardial infarction: A meta-analysis of randomized controlled trials Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)

JOURNAL:American College of Cardiology Article Link

ACC Expert Analysed The 10th Left Main and Coronary Bifurcation Summit

Syed Tanveer Rab, MBBS, FACC


ACC, Jan 10, 2018 - The 10th Left Main and Coronary Bifurcation Summit (CBS) was held in Nanjing, China, November 30 through December 3, 2017. It is a remarkable accomplishment for Professor Shao Liang Chen, MD, FACC, of the University of Nanjing and Nanjing First Hospital to organize this meeting, the largest in the world on these topics, with 1,200 attendees and 60 international faculty representing all continents.


The meeting highlighted the double kissing crush stenting technique trial series I -VII that began in 2004 and its contribution to the current management of left main (LM) and coronary bifurcation stenosis.


The meeting was preceded with a 2-day session on coronary imaging with parallel sessions on coronary atherosclerosis, signaling in coronary plaques, shear stress, and the evolving technology of computed fractional flow reserve. Investigations in shear stress in pulmonary hypertension and pulmonary denervation were also discussed.


Interventional cardiologists from the United States were well represented. Dr. Gregg Stone, MD, FACC, of The Cardiovascular Research Foundation presented the keynote address and moderated several sessions. Gary Mintz, MD, FACC, of The Cardiovascular Research Foundation received the career achievement award for organizing the intravascular imaging sessions for the past 8 years at CBS. There were several combined CBS and JACC: Cardiovascular Intervention sessions moderated by the journal's editor, David Moliterno, MD, FACC, including translational research, sessions for early career cardiologists, and main arena sessions.


There were 140 presentations and 28 live percutaneous coronary intervention (PCI) cases performed by expert international interventionalists on LM and bifurcation stenosis. Tanveer Rab, MD, FACC, from Emory University participated in a complex PCI roadshow involving satellite hospitals and performed the first Impella (Abiomed; Danvers, MA) placement in China for protected LM PCI during a live case demonstration.


Please Click here to read the original report at American College of Cardiology.


References

  1. Chen SL, Zhang JJ, Han Y, et al. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial. J Am Coll Cardiol 2017;70:2605-17.
  2. Li SJ, Ge Z2, Kan J, Zhang JJ, et al. Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study. J Am Coll Cardiol 2017;10:986-95.